Follicular Bronchiolitis in an Adult Male with Common Variable Immune Deficiency
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• FB is a granulomatous-lymphocytic interstitial lung disease (GLILD).
GLILD is a group of non-infectious lung diseases which also includes
lymphocytic interstitial pneumonia, granulomatous disease, and
lymphoid hyperplasia.6,7
• FB is caused by an external stimulus or abnormal immune response
that incites lymphoid hyperplasia.8
• The etiology of FB is idiopathic or associated with collagen vascular
disorders (e.g., Sjogrens, rheumatoid arthritis), hypersensitivity
reactions, acquired immunodeficiencies (typically HIV), and less
commonly, primary immunodeficiencies.9,10 In case reports, FB has
also been linked to primary ciliary dyskinesia, multicentric
Castleman’s disease, primary tuberculosis, and eosinophilia with
elevated IgE.11-14
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BACKGROUND
• Follicular bronchiolitis (FB) in patients with common variable
immune deficiency (CVID) is rarely described and knowledge is
based on case reports, case series, and studies on the individual
disease entities.1-5
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Figure 1. a) Chest radiograph shows an increase in interstitial markings and
hilar adenopathy. Computed tomography demonstrates b) ground glass
peribronchovascular nodules in tree and bud appearance and c) peribronchial
thickening.
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CONCLUSION

• The differential diagnosis of FB includes other types of GLILD, low
grade bronchus associated lymphoid tissue lymphoma, and
sarcoidosis.1

CASE REPORT
The patient was a 43 year-old male with chronic obstructive
pulmonary disease, obesity, sleep apnea, and allergic rhinitis who
presented with increased dyspnea on exertion, chronic mild
productive cough, and occasional wheezing. The patient’s symptoms
had previously improved with an ipratropium bromide/albuterol daily
inhaler. Patient also had a 15 year history of recurrent sinopulmonary
infections. At age 38, a chest radiograph demonstrated hilar
adenopathy. At that time, bronchoscopy samples grew Mycobacterium
gordanae and video assisted thorascopic surgery (VATS) lung biopsy
showed a nonspecific lymphoid granulomatous process. It was thought
to be noninfectious, and acid fast bacilli(AFB) stain was negative. He
worked in a steel mill as a maintenance coordinator and was a member
of the Hazmat and Fire Rescue team. The patient had a history of
hives in reaction to penicillin and the tetanus vaccine. His family
history was negative for collagen vascular disorders or
immunodeficiency.
On examination, the patient’s oxygen saturation was 97% on room
air, respiratory rate 20 breaths per minute, and lungs were clear to
auscultation bilaterally. He had a BMI of 33 kg/m2 and slight left
tympanic membrane retraction with scar. Pulmonary function testing
(PFT) revealed a small airway obstructive pattern, FVC 4.7L(82%),
FEV1 3.08L(68%), FEV1/FVC 65.5%(82%), FEF25-75 1.78L(41%).

After a diagnosis of CVID was made, the patient was started on
400mg/kg of IVIG. VATS was performed, and lung biopsy revealed
follicular bronchiolitis on histopathology (Figure 2). The patient was
then started on prednisone 60mg daily and he was given a month of
clarithromycin to treat a respiratory infection. He required a
prolonged course of corticosteroids that were weaned over one year.
Interval imaging revealed improvement in ground glass opacities but
progression of patient’s NSIP. The patient’s subsequent course was
complicated by pancytopenia requiring splenectomy, and diabetes.
Despite IVIG replacement and improved IgG levels, the patient
continued to have recurrent sinopulmonary infections and was
prescribed daily doxycycline. Infections further decreased after a
40% increase in dose of IVIG. Today the patient’s respiratory
symptoms are much improved, and he has continued treatment with
IVIG for over six years.
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Figure 2. Lung biopsy with a) H&E staining reveals dense lymphoid aggregates
with germinal centers around bronchioles with normal interstitium. b) CD3
staining shows the T-cell lymphocytes forming lymphoid aggregates around
bronchioles. c) CD20 staining shows B-cell lymphocytes forming germinal
centers within the lymphoid aggregates and also demonstrates, together with
CD3 staining, the polyclonal nature of the lymphoid infiltrate. d) Follicular
bronchiolitis with adjacent alveolar wall thickening indicative of Nonspecific
Interstitial Pneumonitis (NSIP).

Laboratory results showed undetectable immunoglobulins
(IgA< 6 mg/dL, IgG< 200 mg/dL, and IgM< 25 mg/dL) and negative
isohemagglutinins. White blood cell count, anti-neutrophil
cytoplasmic antibody, and erythrocyte sedimentation rate were
within normal limits. Tuberculosis skin test, HIV, AFB stains,
hypersensitivity pneumonitis panel and gallium scan were negative.
Imaging was concerning for interstitial lung disease (Figure 1).

• FB in CVID is a rare disease and associated with reduced survival.7
• Diagnosis may be difficult due to common presenting symptoms as
well as variable PFTs and imaging findings.3,8
• Current treatment of FB suggests treating the underlying
immunodeficiency. Some case series report favorable outcomes
with corticosteroids.2,15,16 Cyclosporine and infliximab have been
used in case reports for inability to tolerate steroids and disease
refractory to steroids, respectively.17,18 In terms of treatment, long
term effects and efficacy of IVIG has not been studied.6
• This case is presented to enhance awareness and discuss our
management strategy.
• Further research is required to improve outcomes and
management strategies.
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